These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15542710)
1. Nootropic nefiracetam inhibits proconvulsant action of peripheral-type benzodiazepines in epileptic mutant EL mice. Nakamoto Y; Shiotani T; Watabe S; Nabeshima T; Yoshii M Ann N Y Acad Sci; 2004 Oct; 1025():135-9. PubMed ID: 15542710 [TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors. Shiotani T; Nakamoto Y; Watabe S; Yoshii M; Nabeshima T Brain Res; 2000 Mar; 859(2):255-61. PubMed ID: 10719072 [TBL] [Abstract][Full Text] [Related]
3. Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice. Nakamoto Y; Watabe S; Shiotani T; Yoshii M Brain Res; 1996 Apr; 717(1-2):91-8. PubMed ID: 8738258 [TBL] [Abstract][Full Text] [Related]
4. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. Rashid MH; Ueda H J Pharmacol Exp Ther; 2002 Oct; 303(1):226-31. PubMed ID: 12235255 [TBL] [Abstract][Full Text] [Related]
5. [Mitochondrial benzodiazepine receptors (MBR) in association with neurological disorders]. Yoshii M; Nakamoto Y; Watabe S; Mugishima G; Habu H; Shiotani T; Nabeshima T Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Apr; 18(2):49-54. PubMed ID: 9656233 [TBL] [Abstract][Full Text] [Related]
6. Negative regulation of opioid receptor-G protein-Ca2+ channel pathway by the nootropic nefiracetam. Yoshii M; Furukawa T; Ogihara Y; Watabe S; Shiotani T; Ishikawa Y; Nishimura M; Nukada T Ann N Y Acad Sci; 2004 Oct; 1025():389-97. PubMed ID: 15542741 [TBL] [Abstract][Full Text] [Related]
7. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action. Nomura T; Nishizaki T Brain Res; 2000 Jul; 870(1-2):157-62. PubMed ID: 10869513 [TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats. Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322 [TBL] [Abstract][Full Text] [Related]
9. Cellular mechanism of action of cognitive enhancers: effects of nefiracetam on neuronal Ca2+ channels. Yoshii M; Watabe S; Murashima YL; Nukada T; Shiotani T Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S95-102. PubMed ID: 10850736 [TBL] [Abstract][Full Text] [Related]
10. Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors. Zhao X; Yeh JZ; Narahashi T Ann N Y Acad Sci; 2001 Jun; 939():179-86. PubMed ID: 11462769 [TBL] [Abstract][Full Text] [Related]
11. Effects of Nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Kitano Y; Komiyama C; Makino M; Kasai Y; Takasuna K; Kinoshita M; Yamazaki O; Takazawa A; Yamauchi T; Sakurada S Epilepsia; 2005 Oct; 46(10):1561-8. PubMed ID: 16190926 [TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant and neuroprotective effects of the novel nootropic agent nefiracetam on kainic acid-induced seizures in rats. Kitano Y; Komiyama C; Makino M; Takasuna K; Satoh H; Aoki T; Kinoshita M; Takazawa A; Yamauchi T; Sakurada S Brain Res; 2005 Sep; 1057(1-2):168-76. PubMed ID: 16122714 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T J Pharmacol Exp Ther; 2003 Oct; 307(1):160-7. PubMed ID: 12805478 [TBL] [Abstract][Full Text] [Related]
14. Maximal electroshock increases the density of [3H]Ro 5-4864 binding to mouse cerebral cortex. Basile AS; Weissman BA; Skolnick P Brain Res Bull; 1987 Jul; 19(1):1-7. PubMed ID: 2820550 [TBL] [Abstract][Full Text] [Related]
15. Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Fukunaga K; Narahashi T Neuroscience; 2009 May; 160(2):484-91. PubMed ID: 19272425 [TBL] [Abstract][Full Text] [Related]
16. Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage? Mondadori C; Ducret T; Petschke F Behav Brain Res; 1989 Aug; 34(1-2):155-8. PubMed ID: 2765169 [TBL] [Abstract][Full Text] [Related]
17. Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice. Moriguchi S; Han F; Shioda N; Yamamoto Y; Nakajima T; Nakagawasai O; Tadano T; Yeh JZ; Narahashi T; Fukunaga K J Neurochem; 2009 Jul; 110(1):170-81. PubMed ID: 19457128 [TBL] [Abstract][Full Text] [Related]
18. [Facilitatory actions of the cognitive enhancer nefiracetam on neuronal Ca2+ channels and nicotinic ACh receptors: their intracellular signal transduction pathways]. Yoshii M; Nishizaki T; Watabe S Nihon Yakurigaku Zasshi; 1998 Oct; 112 Suppl 1():41P-43P. PubMed ID: 10190131 [TBL] [Abstract][Full Text] [Related]
19. Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Malykh AG; Sadaie MR Drugs; 2010 Feb; 70(3):287-312. PubMed ID: 20166767 [TBL] [Abstract][Full Text] [Related]
20. Developmental program of epileptogenesis in the brain of EL mice. Murashima YL; Suzuki J; Yoshii M Epilepsia; 2005; 46 Suppl 5():10-6. PubMed ID: 15987247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]